UBS Group upgraded shares of Koninklijke Philips (NYSE:PHG – Free Report) from a sell rating to a neutral rating in a report published on Tuesday morning, MarketBeat Ratings reports.
A number of other brokerages have also issued reports on PHG. BNP Paribas lowered shares of Koninklijke Philips from an outperform rating to an underperform rating in a research note on Wednesday, February 7th. StockNews.com raised shares of Koninklijke Philips from a buy rating to a strong-buy rating in a research report on Thursday, February 8th. Finally, JPMorgan Chase & Co. raised shares of Koninklijke Philips from an underweight rating to a neutral rating in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of Hold and a consensus price target of $19.00.
View Our Latest Stock Report on PHG
Koninklijke Philips Price Performance
Hedge Funds Weigh In On Koninklijke Philips
Several large investors have recently added to or reduced their stakes in PHG. Principal Securities Inc. bought a new stake in Koninklijke Philips during the fourth quarter valued at $27,000. Allspring Global Investments Holdings LLC acquired a new position in shares of Koninklijke Philips in the 1st quarter valued at about $40,000. Fifth Third Bancorp grew its position in shares of Koninklijke Philips by 34.4% during the 1st quarter. Fifth Third Bancorp now owns 3,008 shares of the technology company’s stock valued at $60,000 after buying an additional 770 shares during the last quarter. Allworth Financial LP raised its stake in Koninklijke Philips by 113.3% during the third quarter. Allworth Financial LP now owns 3,242 shares of the technology company’s stock worth $65,000 after acquiring an additional 1,722 shares during the period. Finally, Spire Wealth Management lifted its holdings in Koninklijke Philips by 127.2% in the third quarter. Spire Wealth Management now owns 3,446 shares of the technology company’s stock worth $69,000 after acquiring an additional 1,929 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors.
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
- Five stocks we like better than Koninklijke Philips
- What is Short Interest? How to Use It
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.